Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3541-3550 Newer>

The Motley Fool March 12, 2007 Brian Lawler	Encysive Sings the Blues The tiny drug developer announces a slower-than-expected launch of its lead drug. Investors, take note.
Bio-IT World February 2007 Beth Harper	Meshing EDC with CTMS Many unsolved problems in conducting clinical trials cause delays, wasted resources, team frustration, and even safety issues. Thus, the industry is turning more of its attention away from Electronic Data Capture to Clinical Trial Management Systems.
Bio-IT World February 2007 Kevin Davies	Turbo Charged Pharma Computing An interview with ASPEED Software's Kurt Ziegler on his insights into the latest Top 500 supercomputer rankings and the role of high-performance computing in biopharma.
Bio-IT World February 2007 Robert M. Frederickson	Scramble for CodeLink Customers GE Healthcare has quietly announced that it will stop production of the popular CodeLink array system in 2007. The news was not a complete surprise to some users of the system who felt the company had been backing away from the platform.
Bio-IT World February 2007 Varmazis & Davies	Expanding Galapagos Lands Inpharmatica The recent acquisition by Galapagos of U.K.-based informatics company Inpharmatica puts the Belgian drug discovery company in a healthy position to compete in the competitive service provider segment for the biopharma industry.
Bio-IT World February 2007 John Russell	Ingenuity Launches IPA 5.0 In this pre-launch interview, Ingenuity CTO Ramon Feliciano discusses the major changes to Ingenuity Pathway Analysis that 5.0 will bring.
Bio-IT World February 2007 Mike May	No Limits: The New Look of LIMS As vendors and scientists work towards standardized data formats and improving the tracking of research and results worldwide, laboratory information management systems can pull increasingly more complex sources of information into managing knowledge.
Bio-IT World February 2007 Kevin Davies	Ten Years After: Learn and Confirm Wyeth faces the same problems bedeviling the industry: the soaring cost of development is matched only by the rising attrition rate as once promising drug candidates fall by the wayside. But a new strategy leads to a more science-driven model.
Bio-IT World February 2007 Robert Webber	The Clinical Trial Dilemma Whichever integration technology drives your business, understanding both the IT and Clinical Operations department's needs and expectations is crucial in avoiding an unnecessary dilemma in the decision making process.
Bio-IT World February 2007 Kevin Davies	Obama Declares for Personalized Medicine Barack Obama is one of few members of congress who sees the genomics tidal wave and is doing something about it. Obama may be a Democrat, but drug and biotech industries have reason to hope.
<Older 3541-3550 Newer> Return to current articles.